Brain cell transplant tested for Parkinson's
Disease control
Recruiting now
This is an early safety study for a new cell therapy called NouvNeu001 for people with advanced Parkinson's disease. Doctors will surgically transplant the cells into a specific part of the brain. Participants will need to take anti-rejection medication for about 6 to 9 months to…
Phase: PHASE1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC